

Hepatocyte Specific Antigen (Hep-Par1) (EP265) Rabbit Monoclonal Antibody
Specialties: Anatomic Pathology Gastrointestinal (GI) Pathology
Anti-hepatocyte specific antigen, also known as anti-Hep-Par1, recognizes both benign and malignant liver-derived tissues including such tumors as hepatoblastoma, hepatocellular carcinoma, and hepatic adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating hepatocellular carcinomas with adenoid features from adenocarcinomas, either primary in the liver or metastatic lesions to the liver.1-3 In labeling hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.4,5
- Minervini, MI et al., Mod Pathol. 1997; 10:686-92.
- Chu PG, et al., 2002; 26:978-88.
- Wieczorek T, et al., Am J Clin Pathol. 2002; 118:911-21.
- Fasano M, et al., Mod Pathol. 1998; 11:934-938.
- Maitra A, et al., 2001; 115:689-94.
Specifications
- Reactivity: paraffin
- Visualization: cytoplasmic
- Control: liver
- Dilution Range: 1:50-1:200*
Package Inserts
IFU
- IVD Rev. 2.0 (CMC26431020)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
0.1 mL concentrate | 264R-14 |
0.5 mL concentrate | 264R-15 |
1 mL concentrate | 264R-16 |
1 mL predilute | 264R-17 |
7 mL predilute | 264R-18 |
For in vitro diagnostic (IVD) use in Canada
0.1 mL concentrate | 264R-14 |
0.5 mL concentrate | 264R-15 |
1 mL concentrate | 264R-16 |
1 mL predilute | 264R-17 |
7 mL predilute | 264R-18 |
For in vitro diagnostic (IVD) use in Europe
0.1 mL concentrate | 264R-14 |
0.5 mL concentrate | 264R-15 |
1 mL concentrate | 264R-16 |
1 mL predilute | 264R-17 |
7 mL predilute | 264R-18 |
For research use only (RUO) in Japan
0.1 mL concentrate | 264R-14-RUO |
0.5 mL concentrate | 264R-15-RUO |
1 mL concentrate | 264R-16-RUO |
1 mL predilute | 264R-17-RUO |
7 mL predilute | 264R-18-RUO |
To request information on this product in additional countries, please click the button below.